Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC updates guidance on devices with animal tissues

This article was originally published in Clinica

Executive Summary

The European Commission has published a final draft of a revised guidance document (meddev) on devices utilising tissues or derivatives originating from animals for which a TSE risk is suspected. The purpose of the guidance is to aid the common application of Commission Directive 2003/32/EC on devices containing animal tissues by clarifying some aspects of its interpretation. In particular, it addresses the evaluation performed by the notified body, the activities of the co-ordinating competent authority and the verification role of the other competent authorities. Meddev 2.11/1 revision 2 is dated January 2008, and is available at: http://ec.europa.eu/enterprise/ medical-devices/meddev/2-11-1-rev2-bsetse-january2008.pdf

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel